Metropolis Healthcare Ltd, India’s leading
multinational chain of diagnostic centers has become one of the few
laboratories in Asia to offer PLAC Test. It is a risk stratification test which
identifies the enzyme in the blood vessels. Plac test is a simple blood test
that measures the enzyme activity of Lp-PLA2 level in the body. It is a
cardiovascular-specific inflammatory marker implicated in the formation of
rupture-prone plaque.
Lp-PLA2 (Lipoprotein-associated phospholipase A2)
is a blood vessel enzyme, found to be the second most predictive of heart
attack risk, also warns of vulnerable plaque that could erupt like a volcano.
The higher the level of Lp-PLA2, the higher the risk of CV events i.e., Heart
attack and stroke - even with normal LDL cholesterol. Lp-PLA2 as a biomarker
for cardiovascular risk stratification has been endorsed by various guidelines
published by the American College of Cardiology Foundation/America Heart Association,
the American Stroke Association, the American Association of clinical
endocrinologists in 2010, 2011 and 2012.
“PLAC Test is a simple blood test that assesses
your cardiac health. Cholesterol testing alone is not enough; a traditional
Cholesterol test can miss hidden risks for heart attack. More than 50% of heart
attacks occur in patients with normal cholesterol; rather most cardiovascular
(CV) events i.e., Heart attack and stroke are caused due to rupture of plaque
that is formed by cholesterol deposition in the blood vessels” Said Dr. Rajesh
Bendre, head of department – Immunochemistry & special Immunochemistry,
Metropolis Healthcare Ltd.
In heart diseases, it's known that an unhealthy
lifestyle that includes fatty foods, excess alcohol and smoking dramatically
increases the risk of a stroke. This drives up cholesterol levels and increases
blood pressure. Blood vessels become clogged with fatty deposits that can
dislodge and make their way to the brain, depriving it of vital oxygen.
However, doctors acknowledge that a significant number of people fall victim to
strokes despite having no obvious risk factors.
“Eventually the unstable plaque can rupture, turn
into potential lethal clots and debris loose in bloodstream—causing a stroke or
a heart attack. PLAC test is second generation enzyme linked immunoassay test,
helping doctors with prediction of future strokes and heart attack” says Dr
Arvind Joshi, consultant cardiologist.
ABOUT METROPOLIS HEALTHCARE LTD.
At
Metropolis, what we believe is what we say and what we say is what we do. Being
empathetic to our customers and being committed to their needs is in our DNA.
Metropolis has grown to harness a culture that is open, synergistic,
progressive and scientific in nature.
We are the Pathology Specialists delivering over
15 million tests a year, catering to more than 10,000 Laboratories, Hospitals,
Nursing homes and 2,00,000 Consultants. With 33 years of experience in
delivering accurate reports, Metropolis has earned the reputation of being India's
most respected and only multinational chain of diagnostic centres with presence
in UAE, Sri Lanka, South Africa, Kenya, Mauritius and Ghana.
Driven to
make a difference, our wide network includes 105 state-of-art Laboratories
across India with over 700 collection centres, processing over 4500 varieties
of tests and supported by an efficient team of more than 3000 people. Equipped
with cutting edge technology, innovative
work equipment, expansive logistics network and
rigorous processes, Metropolis ensures and delivers precision and accuracy in
every single test; each time, every time.
In the
last 10 years, Metropolis has expanded into new service lines like Clinical
Trials, Hospital Lab Management, Home Health Services, Preventive Health
Check-ups and Corporate & Wellness Solutions. Metropolis is at the
forefront in adopting cutting edge technologies and services that contribute
new revenue streams and has positioned the company on the pedestal it is today.
Today, we are one of the few laboratories that
has received the CAP (College of American Pathologists), accreditation, the
global gold standard in Laboratory Accreditation. 12 of our laboratories in
India has received the NABL Accreditation (National Accreditation Board for
testing and Calibration Laboratories). In addition, the central laboratory in
Mumbai also adheres to CLIA (Clinical Laboratory Improvement Amendments)
program and also follows the guidelines laid by GCP and GLP. Our unit in South
Africa is accredited by SANAS (South African National Accreditation System is
the only accreditation body approved by South African Government).
Metropolis has been awarded numerous accolades
like the ‘Best Diagnostic Company of the year’ by Modern Medicare in 2006 and
‘Best Diagnostic Company of the Year’ in 2010 by Frost & Sullivan.
Metropolis was also bestowed with ‘Best IT Integration in Customer Service
Management’ at the e-Health World Expo 2011. Metropolis was also honoured with
the ‘Quality Brand Award’ by NEHRDO in 2012. Metropolis won the ‘CMO Asia
Award’ for Best IT practices in Healthcare in 2012.
Metropolis
Healthcare is led by Ameera Shah, Managing Director & CEO. An International
& National Award winners, she was conferred with ‘The Young entrepreneur of
the Year Award’ by GE in 2006 and ‘The Young Achiever of the Year Award’ at the
CMO Asia Awards in 2011. She was also the recipient of the prestigious ‘Young
Entrepreneur of the Year Award’ in 2011 organised by Entrepreneur India and
Bloomberg. She has been honoured with ‘Women Leadership award’ at the World
Women Leadership and Congress awards 2014.
Recently she has been chosen as one of the most respected leaders under
40 years by Economic Times & Spencer Stuart (2014).
No comments:
Post a Comment